Current Liabilities
Income Taxes Payable
Neurocrine Biosciences Income Taxes Payable increased by 174.1% to $186.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 633.9%, from $25.40M to $186.40M. Over 3 years (FY 2022 to FY 2025), Income Taxes Payable shows an upward trend with a 96.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ4 2022
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase often reflects higher taxable income, while a decrease may indicate tax payments made or lower taxable earnings.
Detailed definition
This represents the current portion of income tax obligations owed to various government taxing authorities based on tax...
Peer comparison
Common across all profitable corporations, varying based on effective tax rates and jurisdictional tax laws.
Metric ID:
income_taxes_payableHistorical Data
12 periods
| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.00M | $72.70M | $96.00M | $24.80M | $111.00M | $134.90M | $160.70M | $25.40M | $25.70M | $195.50M | $68.00M | $186.40M |
| QoQ Change | — | +707.8% | +32.0% | -74.2% | +347.6% | +21.5% | +19.1% | -84.2% | +1.2% | +660.7% | -65.2% | +174.1% |
| YoY Change | — | — | +966.7% | — | — | +85.6% | +67.4% | +2.4% | -76.8% | +44.9% | -57.7% | +633.9% |
Range$9.00M – $195.50M
CAGR+201.0%
Avg YoY Growth+208.3%
Median YoY Growth+56.2%
Income Taxes Payable at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's income taxes payable?
- Neurocrine Biosciences (NBIX) reported income taxes payable of $186.40M in Q1 2026.
- How has Neurocrine Biosciences's income taxes payable changed year-over-year?
- Neurocrine Biosciences's income taxes payable increased by 633.9% year-over-year, from $25.40M to $186.40M.
- What is the long-term trend for Neurocrine Biosciences's income taxes payable?
- Over 3 years (2022 to 2025), Neurocrine Biosciences's income taxes payable has grown at a 96.2% compound annual growth rate (CAGR), from $9.00M to $68.00M.
- What does income taxes payable mean?
- The amount of income tax the company owes to government authorities for the current period.